Total Funding
24
2
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
467923
Thermosome is developing drug candidates leveraging its proprietary drug delivery technology,
- Martin Hossann: Co-Founder and Principal Scientist
- Frank Hermann: Chief Medical Officer
About the Company
Thermosome is an emerging biopharmaceutical company headquartered in the Innovation and Start-Up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich, Germany. Our technology was invented by Prof. Dr. Hansjörg Eibl at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany, and applied, among others, in various in
vitro and in vivo studies by a research group at the University Hospital of the Ludwig-Maximilians-Universitaet Munich, Germany. Based on inspiring results from this research including the preclinical proof-of-concept in various animal species, Thermosome started its operational activities in late 2015.
